Background <p>The management of psychotropic medication in older adults is a challenge for every healthcare professional, but data concerning community pharmacists are scarce in the literature.</p> Aim <p>Our objectives were i) to understand the difficulties encountered by community pharmacists in managing older adults on psychotropic medication, and ii) to identify potential solutions to the difficulties discussed.</p> Method <p>A qualitative study by focus group was proposed to all community pharmacists in the vicinity of the university hospital of Angers, France, between May and June 2023. An interview guide was established based on data from literature, with open-ended questions covering 5 categories: management of adverse drug reactions, patient counselling and dispensing, management of psychotropic misuse, pharmacological knowledge, professional relationship and communication. Data were analysed using thematic analysis with an inductive approach.</p> Results <p>Four consecutive focus groups were conducted with 17 community pharmacists. Three themes emerged from the various discussions: communication-related issues (e.g. patients refusing to discuss or consider the pharmacist's advice, lack of care-continuity between hospital and community pharmacy); system-related issues (e.g. limitation of time available for patient counselling, lack of access to the patient's clinical details); and psychotropic-related issues (e.g. different perceptions of the risk–benefit ratio between patients and pharmacists, suspected dependence leading to overuse).</p> Conclusion <p>The challenges of managing psychotropic medications in older people in community pharmacies are many, but there are solutions. They mainly revolve around interprofessional collaboration, improving the patient pathway, particularly the link between hospital and community pharmacy, and improving training for pharmacists in optimising psychotropic medication.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Community pharmacists' perceptions of their challenges in relation to older adults prescribed psychotropic medications: a focus-group study

  • Mathieu Corvaisier,
  • Lucile Come,
  • Housni Boughammoura,
  • Cédric Annweiler,
  • Laurence Spiesser-Robelet

摘要

Background

The management of psychotropic medication in older adults is a challenge for every healthcare professional, but data concerning community pharmacists are scarce in the literature.

Aim

Our objectives were i) to understand the difficulties encountered by community pharmacists in managing older adults on psychotropic medication, and ii) to identify potential solutions to the difficulties discussed.

Method

A qualitative study by focus group was proposed to all community pharmacists in the vicinity of the university hospital of Angers, France, between May and June 2023. An interview guide was established based on data from literature, with open-ended questions covering 5 categories: management of adverse drug reactions, patient counselling and dispensing, management of psychotropic misuse, pharmacological knowledge, professional relationship and communication. Data were analysed using thematic analysis with an inductive approach.

Results

Four consecutive focus groups were conducted with 17 community pharmacists. Three themes emerged from the various discussions: communication-related issues (e.g. patients refusing to discuss or consider the pharmacist's advice, lack of care-continuity between hospital and community pharmacy); system-related issues (e.g. limitation of time available for patient counselling, lack of access to the patient's clinical details); and psychotropic-related issues (e.g. different perceptions of the risk–benefit ratio between patients and pharmacists, suspected dependence leading to overuse).

Conclusion

The challenges of managing psychotropic medications in older people in community pharmacies are many, but there are solutions. They mainly revolve around interprofessional collaboration, improving the patient pathway, particularly the link between hospital and community pharmacy, and improving training for pharmacists in optimising psychotropic medication.